In conclusion, our data preliminarily reveals that AMD3100 may alleviate LPS-induced ALI by modulating multiple chemokines to suppress the TLR/NF-κB signaling pathway. This evidence concerns the gene NFKB1 and acute respiratory distress syndrome.